# The Future of Blood Pressure Monitoring: Apple Watch and Huawei Watch D
As the landscape of wearable technology progresses, health tracking capabilities have emerged as a priority for brands such as Apple and Huawei. A highly awaited feature in the Apple Watch series has been the capacity to monitor blood pressure. Nevertheless, recent updates suggest that this functionality has encountered setbacks, especially concerning the forthcoming Apple Watch Series 10. In contrast, Huawei has already advanced in this domain with its Huawei Watch D.
## Apple Watch Blood Pressure Monitoring Delayed
A recent report reveals that the much-anticipated blood pressure monitoring feature for the Apple Watch has been postponed due to design modifications in the Series 10 model. Although specific details regarding the challenges faced during testing are not public, Apple’s intent to provide a dependable health monitoring feature in the future is evident.
In the past, there were talks about integrating blood pressure monitoring into earlier Apple Watch versions. Reports from 2021 pointed to its debut with the Apple Watch Series 7, yet this did not happen. Bloomberg’s Mark Gurman, a trustworthy source for Apple insights, suggested in 2022 that the feature might appear in Series 10, but it seems complications during testing have resulted in additional delays.
## What Can We Expect When It Launches?
Conventional blood pressure assessment generally requires bulky apparatus and a pressure cuff. This technique involves inflating a cuff around the arm to impede blood flow, then gradually releasing it to gauge the pressure at which blood starts flowing again. This method can be inconvenient and is not always suitable for frequent use.
Alternatively, the Apple Watch is anticipated to adopt a more advanced strategy. By using technology akin to its existing heart-rate sensor, the Apple Watch will evaluate the pulse wave shape at the wrist. This information can yield insights into arterial stiffness, a significant element affecting blood pressure. While this method shows promise, it is important to note that present wrist-based blood pressure monitors, like the Huawei Watch D, often face accuracy issues.
### Accuracy Concerns
The Mayo Clinic has indicated that wrist blood pressure monitors often produce unreliable readings, typically overestimating blood pressure values. They suggest that users should calibrate these devices alongside measurements obtained from healthcare professionals via traditional cuff methods. The clinic also recommends users maintain proper positioning and technique when taking readings to reduce errors.
Considering these challenges, it is likely that Apple will prioritize enhancing the accuracy of its blood pressure monitoring feature prior to its eventual rollout. One possible approach for improving accuracy involves utilizing artificial intelligence (AI) models to analyze data gathered from users.
## Huawei Watch D: A Step Ahead
As Apple continues to develop its blood pressure monitoring feature, Huawei has already launched the Huawei Watch D, which encompasses this function. The Huawei Watch D employs a more traditional method for blood pressure measurement by integrating a miniaturized pressure cuff within the watch itself. This innovation enables users to obtain more accurate readings from their wrist.
Nonetheless, like several wrist-based monitors, the Huawei Watch D is not free from limitations. Users should calibrate their readings with professional assessments to guarantee precision. Despite these challenges, the Huawei Watch D signifies a significant advancement in making blood pressure monitoring more accessible and convenient for users.
## Conclusion
The competition to integrate effective blood pressure monitoring into wearable technology is intensifying, with Apple and Huawei at the forefront. While Apple confronts delays in launching its feature due to design obstacles, Huawei has already made progress with the Watch D. As this technology develops, consumers can anticipate more precise and user-friendly health monitoring options in the future. Whether via Apple’s groundbreaking methods or Huawei’s current offerings, the outlook for blood pressure monitoring appears encouraging.
